Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Big Yellow Q1 revenues up 3pc

(Sharecast News) - Self-storage group Big Yellow said on Thursday that total revenues had increased in the three months ended 30 June on the back of strong average rate growth. Big Yellow said Q1 store revenue was up 3% at £51.1m, while total revenues also rose 3%, to £51.5m, with average net rents growing 5% to £35.67 per square foot.

Big Yellow said occupancy across all 109 stores increased by 47,000 square feet compared to a gain of 220,000 square feet in the same quarter a year earlier, while closing occupancy rose by 0.7ppts to 79.4% quarter-on-quarter but ws down 2.4ppts year-on-year.

Chief executive Jim Gibson said: "As stated in our May results, we saw some softening of demand and loss of occupancy at the start of the quarter due to elevated levels of macroeconomic uncertainty. Despite this we have delivered strong average rate growth of 5% through our yield management processes, which has resulted in 3% revenue growth for the quarter compared to last year.

"We saw some improvement in demand through the quarter, which has continued into July, with improved year-on-year occupancy performance. Our customer base remains stable with move-outs lower than last year."

As of 0845 BST, Big Yellow shares were up 2.41% at 933.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.